Table 1 Patient characteristics across different cohorts

From: Noninvasive evaluation and clinical value prediction of tumor-infiltrating neutrophil-to-T-cell ratio in pancreatic ductal adenocarcinoma

Characteristics

TCGA (n = 143)

CPTAC (n = 59)

Center A (n = 158)

External validation (n = 42)

Age (years), mean ± SD

64.69 ± 10.94

65.00 ± 10.90

62.99 ± 10.23

64.90 ± 10.89

Gender, n (%)

 Female

67 (46.9)

30 (50.8)

58 (36.7)

21 (50.0)

 Male

76 (53.1)

29 (49.2)

100 (63.3)

21 (50.0)

 BMI (kg/m²), mean ± SD

-

25.92± 4.47a

22.39 ± 3.36

21.79 ± 3.42

Location of lesion, n (%)

 Head

109 (76.2)

51 (86.4)

121 (76.6)

26 (61.9)

 Body or tail

19 (13.3)

7 (11.9)

37 (23.4)

16 (38.1)

 Overlapping

1 (0.7)

0 (0)

0 (0)

0 (0)

 Unknown

14 (9.8)

1 (1.7)

0 (0)

0 (0)

T Stage, n (%)

 T1

4 (2.8)

0 (0)

36 (22.8)

3 (7.1)

 T2

17 (11.9)

10 (16.9)

97 (61.4)

28 (66.7)

 T3

118 (82.5)

41 (69.5)

25 (15.8)

10 (23.8)

 T4

3 (2.1)

3 (5.1)

0 (0)

1 (2.4)

 Tx

0 (0)

1 (1.7)

0 (0)

0 (0)

 Unknown

1 (0.7)

4 (6.8)

0 (0)

0 (0)

N Stage, n (%)

 N0

37 (25.9)

7 (11.9)

98 (62.0)

24 (57.1)

 N1

105 (73.4)

41 (69.5)

45 (28.5)

15 (35.7)

 N2

0 (0)

7 (11.9)

15 (9.5)

3 (7.1)

 Nx

1 (0.7)

1 (1.7)

0 (0)

0 (0)

 Unknown

0 (0)

3 (5.1)

0 (0)

0 (0)

M Stage, n (%)

 M0

66 (46.2)

45 (76.3)

158 (100)

39 (92.9)

 M1

3 (2.1)

3 (5.1)

0 (0)

3 (7.1)

 Mx

74 (51.7)

9 (15.3)

0 (0)

0 (0)

 Unknown

0 (0)

2 (3.4)

0 (0)

0 (0)

  1. aFour patients were excluded due to loss of BMI information.